These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9734368)

  • 21. Search for AIDS vaccine advances.
    Hum Vaccin Immunother; 2012 Feb; 8(2):151. PubMed ID: 22745942
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV-1 DNA/MVA vaccination reduces the per exposure probability of infection during repeated mucosal SHIV challenges.
    Ellenberger D; Otten RA; Li B; Aidoo M; Rodriguez IV; Sariol CA; Martinez M; Monsour M; Wyatt L; Hudgens MG; Kraiselburd E; Moss B; Robinson H; Folks T; Butera S
    Virology; 2006 Aug; 352(1):216-25. PubMed ID: 16725169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
    Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
    Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection.
    Pope M; Haase AT
    Nat Med; 2003 Jul; 9(7):847-52. PubMed ID: 12835704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
    Bhardwaj N; Walker BD
    Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel strategies toward the development of an effective vaccine to prevent human immunodeficiency virus infection or acquired immunodeficiency virus.
    Ensoli B; Cafaro A
    AIDS Clin Rev; 2000-2001; ():23-61. PubMed ID: 10999215
    [No Abstract]   [Full Text] [Related]  

  • 27. CTL ontogeny and viral escape: implications for HIV-1 vaccine design.
    Yang OO
    Trends Immunol; 2004 Mar; 25(3):138-42. PubMed ID: 15036041
    [No Abstract]   [Full Text] [Related]  

  • 28. Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques.
    Baba TW; Liska V; Khimani AH; Ray NB; Dailey PJ; Penninck D; Bronson R; Greene MF; McClure HM; Martin LN; Ruprecht RM
    Nat Med; 1999 Feb; 5(2):194-203. PubMed ID: 9930868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fifty volunteer for live-vaccine trial.
    James JS
    AIDS Treat News; 1997 Oct; (No 280):1-2. PubMed ID: 11364735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoprophylaxis of HIV infection: moving forward with caution.
    Grant RM; Wainberg MA
    J Infect Dis; 2006 Oct; 194(7):874-6. PubMed ID: 16960773
    [No Abstract]   [Full Text] [Related]  

  • 31. CD4+ T-cell subsets: what really counts in preventing HIV disease?
    Mason RD; De Rose R; Kent SJ
    Expert Rev Vaccines; 2008 Mar; 7(2):155-8. PubMed ID: 18324885
    [No Abstract]   [Full Text] [Related]  

  • 32. Feasibility of developing live attenuated HIV vaccines: conclusions and recommendations. World Health Organization Working Group.
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):221-2. PubMed ID: 8198875
    [No Abstract]   [Full Text] [Related]  

  • 33. Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: preclinical studies in the SHIV-rhesus model.
    Nehete PN; Nehete BP; Manuri P; Hill L; Palmer JL; Sastry KJ
    Vaccine; 2005 Mar; 23(17-18):2154-9. PubMed ID: 15755586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current world literature.
    Curr Opin HIV AIDS; 2012 Jan; 7(1):86-95. PubMed ID: 22156801
    [No Abstract]   [Full Text] [Related]  

  • 35. Vaccines against HIV.
    Verani P; Titti F; Corrias F; Belli R; Di Fabio S; Geraci A; Konga-Mogtomo M; Maggiorella MT; Sernicola L
    J Biol Regul Homeost Agents; 1997; 11(1-2):82-7. PubMed ID: 9418170
    [No Abstract]   [Full Text] [Related]  

  • 36. AIDS vaccine: new ideas from old approaches.
    Beale AJ
    J R Soc Med; 2003 Jul; 96(7):347-8. PubMed ID: 12835449
    [No Abstract]   [Full Text] [Related]  

  • 37. Attenuated vaccines for AIDS.
    Victorino RM; Sousa AE
    Lancet; 1995 Jul; 346(8968):179. PubMed ID: 7603240
    [No Abstract]   [Full Text] [Related]  

  • 38. Concerning the anti-major histocompatibility complex approach to HIV type 1 vaccine design.
    Luscher MA; Dela Cruz CS; MacDonald KS; Barber BH
    AIDS Res Hum Retroviruses; 1998 May; 14(7):541-4. PubMed ID: 9591707
    [No Abstract]   [Full Text] [Related]  

  • 39. The next steps in HIV vaccine development.
    Ada G; Koff W; Petricciani J
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1317-9. PubMed ID: 1466949
    [No Abstract]   [Full Text] [Related]  

  • 40. Virology. A bid to thwart HIV with shot of long-lasting drug.
    Cohen J
    Science; 2014 Mar; 343(6175):1067. PubMed ID: 24604173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.